HowShorted

How shorted is Cogent Biosciences, Inc.?

More shorted than 82% of the 2,877 ranked US companies

10.47%
of shares outstanding reported short · settlement date 31 Jul 2026
vs previous report
+0.78
5 reports (~10 weeks)
+3.94
Aggregate net short position time series for Cogent Biosciences, Inc.
Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Cite this page

History

Settlement dateShort %Change
31 Jul 202610.47%+0.78
15 Jul 20269.69%+0.12
30 Jun 20269.57%+1.70
15 Jun 20267.87%+1.13
29 May 20266.74%+0.21
15 May 20266.53%−0.71
30 Apr 20267.24%−0.18
15 Apr 20267.42%−3.32
31 Mar 202610.74%+1.13
13 Mar 20269.61%−0.32
27 Feb 20269.93%−0.10
13 Feb 202610.03%−1.86
30 Jan 202611.89%+0.34
15 Jan 202611.55%+0.92
31 Dec 202510.63%+0.29
15 Dec 202510.34%+0.38
28 Nov 20259.96%−0.91
14 Nov 202510.87%+0.09
31 Oct 202510.78%−0.87
15 Oct 202511.65%−0.53
30 Sep 202512.18%+1.41
15 Sep 202510.77%+1.42
29 Aug 20259.35%+0.04
15 Aug 20259.31%−1.77
31 Jul 202511.08%–

Frequently asked questions

How shorted is Cogent Biosciences, Inc. right now?
10.47% of Cogent Biosciences, Inc.'s (COGT) shares outstanding were reported short for settlement date 31 Jul 2026, per FINRA's consolidated short interest report.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.